Atreides Management
No summary available yet.
Gavin Baker is one of the most respected growth investors in the game, with a track record that speaks for itself from his Fidelity days. The guy doesn't chase fads - he finds exceptional companies and holds them through thick and thin. That said, Atreides is essentially Gavin's show, so you're betting on one person's judgment. He's incredibly thoughtful and has genuine operational insights, but the fund is still relatively new as an independent entity. If you can get him interested, he's the kind of investor who will stick with you through tough times and genuinely help you think through long-term strategy.
- —Best for: Later-stage companies needing patient, conviction-driven capital
- —Watch out for: One-person show risk despite stellar track record
- —Known for: Exceptional stock-picking and long-term thinking
Atreides Management is a long-term focused investment firm that backs exceptional companies across public and private markets. They emphasize deep fundamental research and patient capital deployment, particularly in technology, healthcare, and other growth sectors where they can add strategic value.
Multi-stage investor from growth equity through public markets, with a heavy focus on technology, healthcare, and consumer companies. Known for writing larger checks ($10M+) in later-stage rounds and taking concentrated positions in their highest conviction names.
Former Fidelity star portfolio manager who ran the $15B Fidelity OTC Fund with exceptional returns. Known for his deep tech analysis and ability to spot winners early, then ride them for years. Highly respected by founders for his long-term thinking and operational insights.
Have a specific question about Atreides Management?
Ask Bernie →